| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 3.530 | 45.304 | 44.751 | 64.061 |
| Total Income - EUR | - | - | - | - | - | - | 3.530 | 45.310 | 44.751 | 70.073 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.401 | 24.879 | 44.804 | 71.349 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.129 | 20.431 | -53 | -1.275 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 2.024 | 19.261 | -501 | -3.336 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Ginecovitae S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 9.657 | 29.544 |
| Current Assets | - | - | - | - | - | - | 2.797 | 24.325 | 19.477 | 35.541 |
| Inventories | - | - | - | - | - | - | 0 | 304 | 0 | 269 |
| Receivables | - | - | - | - | - | - | 2.264 | 18.158 | 16.692 | 30.966 |
| Cash | - | - | - | - | - | - | 532 | 5.864 | 2.785 | 4.307 |
| Shareholders Funds | - | - | - | - | - | - | 2.064 | 21.331 | 20.852 | 17.400 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 733 | 2.994 | 8.283 | 47.686 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Ginecovitae S.r.l.